A single institution experience of the Manta closure device in endovascular aortic repair
Vascular · 2025
DOI: 10.1177/17085381241256191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular, 2025. Verfasst von Ali Moonan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Radiology, Kent and Canterbury Hospital, Canterbury, UK. Hauptthemen laut MEDLINE: Endovascular Procedures, Hemostatic Techniques, Vascular Closure Devices, Femoral Artery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Background
Majority of EVAR procedures are performed with percutaneous arterial access, unless there is severe steno-occlusive disease in the common femoral arteries (CFA). We present our experience of using MANTA closure device with a retrospective evaluation of its safety and efficacy, in the elective setting, and in the emergent setting for ruptured aortic aneurysm. Design and methods Between Feb 2021 and May 2023 a total of 75 EVAR procedures were closed with a Manta device. Data was collected prospectively and analysed retrospectively. In 75 patients, 128 CFAs were closed with a Manta closure device including 4 emergent ruptured aneurysms.
Results
67 male and 8 female patients with a median age of 77 years had percutaneous EVAR using Manta as a closure device. 128 CFAs were closed with Manta closure device. 3% (4/128) had deployment failures, with three requiring surgical cut down and closure. In one patient, a second Manta device deployment achieved satisfactory haemostasis. Three deployments were complicated by pseudoaneurysms of the CFA, all requiring no further interventions/treatment. No death related to severe haemorrhage from device failure. The pre- and post-procedure CFA puncture site AP diameter was recorded in a total of 106 cases with appropriate follow-up. 66% of these (70/106) had no reduction in CFA diameter post Manta closure. 34% (36/106) had some reduction of vessel AP size CFA post EVAR. No adverse features or further treatment was required due to reduction of vessel diameter in these cases (ongoing yearly surveillance).
Conclusions
Manta closure device is safe and easy to deploy with an overall success rate of 97%. There is a short learning curve. Ultrasound assessment and precise puncture at the healthy section of femoral artery are the key to achieve successful haemostasis with Manta closure device. Our findings suggest there is an association of non-clinically significant mild reduction in CFA vessel AP diameter post Manta closure device, which does not require further intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interventional Radiology, Kent and Canterbury Hospital, Canterbury, UK.
ORCID-Profile: Ali Moonan
Zitieren
APA
Moonan, A., Hameed, A., Nachiappan, S., Das, N., Pantos, A., Valencia, D., Kaikini, R., & Prashar, A. (2025). A single institution experience of the Manta closure device in endovascular aortic repair. Vascular. https://doi.org/10.1177/17085381241256191
Vancouver
Moonan A, Hameed A, Nachiappan S, Das N, Pantos A, Valencia D, et al. A single institution experience of the Manta closure device in endovascular aortic repair. Vascular. 2025. doi:10.1177/17085381241256191
BibTeX
@article{Moonan2025,
author = {Moonan, Ali and Hameed, Aisha and Nachiappan, Subramanian and Das, Neelan and Pantos, Athanasios and Valencia, Dexter and Kaikini, Robert and Prashar, Akash},
title = {A single institution experience of the Manta closure device in endovascular aortic repair},
journal = {Vascular},
year = {2025},
doi = {10.1177/17085381241256191}
}
EUVIMED